prof. dr. Tim Lammens
- ORCID iD
-
0000-0001-8733-4027
Show
Sort by
-
- Journal Article
- A1
- open access
In vivo stabilization of a less toxic asparaginase variant leads to a durable antitumor response in acute leukemia
-
European standard clinical practice : key issues for the medical care of individuals with familial leukemia
-
- Journal Article
- A1
- open access
In vivo stabilization of a less toxic asparaginase variant leads to a durable anti-tumor response in acute leukemia
-
- Conference Paper
- C3
- open access
Mutational permutations of a single amino acid exert divergent phenotypic effects in human, mice and cellular models of SAMD9L bone marrow failure disorder
-
- Miscellaneous
- open access
Correction to : functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignancies
-
- Journal Article
- A2
- open access
Practice guidelines for the therapeutic drug monitoring of asparaginase in acute lymphoblastic leukemia
-
Deciphering the non-coding landscape of pediatric acute myeloid leukemia
-
Whole genome sequencing and inheritance-based variant filtering as a tool for unraveling missing heritability in pediatric cancer
-
- Journal Article
- A1
- open access
Targeted therapy in juvenile myelomonocytic leukemia : where are we now?
-
- Journal Article
- A1
- open access
Evaluation of PEG-L-asparaginase in asparagine suppression and anti-drug antibody development in healthy Beagle dogs : a multi-phase preclinical study